Outset Medical Q2 adjusted loss per share narrows less than expected

Outset Medical

06/08/2026 21:29

Overview
U.S. dialysis technology firm's Q2 revenue rose 1% yr/yr to $31.6 mln
Adjusted loss per share for Q2 missed analyst expectations
Company signed $40 mln, three-year agreement with HCA Healthcare to refresh Tablo fleet

Outlook
Outset Medical reiterates 2026 revenue guidance of $125 mln to $130 mln
Company continues to expect full-year non-GAAP gross margin in the low-40% to mid-40% range

Result Drivers
SERVICE REVENUE GROWTH - Service and other revenue increased 17% yr/yr, offsetting a decline in product revenue
NEW CONTRACTS - Co signed a three-year, $40 mln agreement with HCA Healthcare to refresh Tablo systems
GROSS MARGIN IMPROVEMENT - Gross margin expanded to 42%, up from 37.8% in the prior-year period

Company press release: ID:nGNX3xMDfz

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$31.64 mln
 
Q2 Adjusted Loss Per Share
Miss
$0.80
$0.72 (3 Analysts)
Q2 Net Loss
 
$17.98 mln
 
Q2 Gross Margin
 
42.00%
 
Q2 Gross Profit
 
$13.28 mln
 
Q2 Loss Per Basic Share
 
$0.97
 
Q2 Operating Expenses
 
$28.96 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Outset Medical, Inc. is $7.00, about 36.7% above its August 5 closing price of $5.12

Reuters Recommended Reads
Aug 4 - DaVita flags lower revenue per treatment, reaffirms annual forecast
Aug 4 - Berkshire sells 182,980 DaVita shares, still has 45% stake in dialysis provider
Aug 4 - Germany's Fresenius SE Q2 core EPS rises 14%, lifts 2026 outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)